FEMPATCH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fempatch, and what generic alternatives are available?
Fempatch is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in FEMPATCH is estradiol. There are seventy-five drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fempatch
A generic version of FEMPATCH was approved as estradiol by BARR LABS INC on October 22nd, 1997.
Summary for FEMPATCH
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Patent Applications: | 7,167 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FEMPATCH at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FEMPATCH
US Patents and Regulatory Information for FEMPATCH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FEMPATCH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FEMPATCH
See the table below for patents covering FEMPATCH around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0483105 | Dispositifs pour la délivrance transdermique de médicaments utilisant des esters d'acides gras ou des éthers d'alcohols gras des alcanediols pour améliorer l'absorption. (Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers.) | ⤷ Try a Trial |
Australia | 3853089 | ⤷ Try a Trial | |
Australia | 8249887 | ⤷ Try a Trial | |
Norway | 904317 | ⤷ Try a Trial | |
Denmark | 241090 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FEMPATCH
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1214076 | 49/2008 | Austria | ⤷ Try a Trial | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612 |
1453521 | 15C0050 | France | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
0584952 | 99C0004 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ESTRADIOL, HEMIHYDRATE, NORETHISTERONE, ACETATE; NAT. REGISTRATION NO/DATE: NL 23753 19981210; FIRST REGISTRATION: SE - 14 007 19980306 |
0285237 | 95C0008 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ESTRADIOL, HEMIHYDRATE; NAT. REGISTRATION NO/DATE: NL 19489 19941107; FIRST REGISTRATION: FR - NL 19489 19941107 |
1214076 | SZ 49/2008 | Austria | ⤷ Try a Trial | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |